Mallinckrodt and Endo plan merger as they look to recover from opioid litigation
The new entity will be listed on the New York Stock Exchange and is expected to generate pro forma revenue of $3.6 billion in ...
Mallinckrodt, Endo Merger to Create Diversified Pharmaceuticals Firm
Drugmaker Mallinckrodt struck a deal to buy Endo in an effort to build a diversified pharmaceuticals company with a hefty U.S ...
Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger
Mallinckrodt and Endo , drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced ...
GlobalData on MSN6d
Mallinckrodt and Endo sign $6.7bn merger deal
The two companies are merging after previously filing for bankruptcy due to opioid-related litigation and financial losses.
MyChesCo on MSN4d
Mallinckrodt and Endo Announce Merger to Build Diversified Pharmaceuticals Powerhouse
Pharmaceutical leaders Mallinckrodt plc and Endo, Inc. (OTCQX: NDOI) have entered an agreement to merge, creating a global, ...
Drugmakers Mallinckrodt, Endo in talks to merge, source says
Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the ...
BioSpace6d
Troubled Drugmakers Mallinckrodt, Endo Officially Announce $6.7B Merger
As per the Thursday release, Endo will be folded into Mallinckrodt, which will then continue as the holding entity for the ...
Fierce Pharma6d
Mallinckrodt, Endo look to carve out brighter future through $6.7B merger
Mallinckrodt and Endo are merging in a cash and stock deal worth some $6.7 billion, the companies said Thursday. Under the ...
Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal
Endo shareholders will get $80 million in cash and own 49.9% of the combined company, while Mallinckrodt shareholders will ...
GEN - Genetic Engineering and Biotechnology News6d
Mallinckrodt, Endo Plan $6.7B Merger
The Mallinckrodt-Endo combination will have approximately 5,700 employees at closing, as well as 17 manufacturing facilities, 30 distribution centers, and an operating footprint primarily located in ...
Drugmakers Mallinckrodt and Endo Are in Talks to Merge
Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people ...
Wall Street Journal6d
Mallinckrodt, Endo Merger to Create Diversified Pharmaceuticals Firm
Drugmaker Mallinckrodt struck a deal to buy Endo in an effort to build a diversified pharmaceuticals company with a hefty U.S. footprint. The companies said Thursday they reached a definitive ...